Back to results
Completed

HER2-directed Biosimilar in Breast Cancer: Real World ePRO

NCT05234021

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Andreas Trojan

Horgen, Canton of Zurich, Switzerland

+2 additional locations

View on ClinicalTrials.gov
HER2-directed Biosimilar in Breast Cancer: Real World ePRO — TrialFind